A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
Clinical trial NCT04897022 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04897022
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-10
- Primary completion
- 2026-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.